Evidence map›Paper›PMID 30793483›Full record

ArticleJournal of cellular and molecular medicine2019

A novel role of HuR in -Epigallocatechin-3-gallate (EGCG) induces tumour cells apoptosis.

Wenxuan Jian, Shuhuan Fang, Tongkai Chen, Jiansong Fang, Yousheng Mo, Dongli Li, Sha Xiong, Wei Liu, Lei Song, Jiangang Shen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. HuR controls glutaminase RNA metabolism.Nature communications · 2024
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Wenxuan JianDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Shuhuan FangDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Tongkai ChenDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Jiansong FangDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Yousheng MoDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Dongli LiDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Sha XiongDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Wei LiuDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Lei SongDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Jiangang ShenDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Yong XiaDepartment of Clinical Laboratory, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China.
Qi WangDME Center, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Honghai HongDepartment of Clinical Laboratory, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China.ORCID 0000-0003-2138-9118
Guangzhou University of Chinese Medicine · CNThird Affiliated Hospital of Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADAM10 ProteinAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAnimalsApoptosisbcl-2-Associated X ProteinCatechinELAV-Like Protein 1Gene Expression Regulation, NeoplasticHep G2 CellsHumansMAP Kinase Signaling SystemMembrane ProteinsNeoplasmsPC12 CellsProto-Oncogene Proteins c-bcl-2ADAM10 ProteinADAM10 protein, humanAmyloid beta-Protein PrecursorAmyloid Precursor Protein Secretasesbcl-2-Associated X ProteinCatechinELAV-Like Protein 1epigallocatechin gallateMembrane ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID30793483
PMCPMC6484420
OpenAlexW2915938134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.